Abstract
Bone mass and inflammation are implicated in the pathogenesis of osteoporosis. We hypothesized that leptin and leptin receptor gene might be associated with osteoporosis by activating the inflammatory pathway. Therefore, we analyzed polymorphisms of the leptin (gene symbol, LEP) and leptin receptor (gene symbol, LEPR) genes and determined their associations with proinflammatory cytokine levels in patients with osteoporosis. We assessed polymorphisms in LEP (−2548G > A) and LEPR (Lys109Arg, Gln223Arg, and Lys656Asn) and calculated odds ratios for the genotype and allele distributions between patients and controls. Serum leptin, soluble leptin receptor, interleukin (IL)-1, IL-6, IL-7, and tumor necrosis factor (TNF) levels were measured by enzyme-linked immunosorbent assays (ELISA) and were verified by in vitro lymphocyte proliferation assays and ELISAs. We found a higher frequency of the A allele for LEP at −2548 in patients with osteoporosis compared with the control group. The A allele was associated with differences in serum leptin, soluble leptin receptor, IL-1, IL-6, and TNF levels compared with the wild-type G allele (p < 0.05). The G allele in Lys109Arg and Gln223Arg was associated with increased risk of osteoporosis and with differences in serum leptin, soluble leptin receptor, IL-1, IL-6, and TNF levels compared with the wild-type A allele (p < 0.05). The Lys656Asn genotype was not associated with the risk of osteoporosis. In vitro lymphocyte proliferation assays and ELISAs confirmed these results. Polymorphisms in LEP and LEPR are associated with increased risk of osteoporosis, possibly by increasing the expression of proinflammatory cytokines.

Similar content being viewed by others
References
Y. Dionyssiotis, Bone loss and fractures in multiple sclerosis: focus on epidemiologic and physiopathological features. Int. J. Gen. Med. 2011(4), 505–509 (2011)
M.E. Nadia, A.S. Nazrun, M. Norazlina, N.M. Isa, M. Norliza, S. Ima Nirwana, The anti-inflammatory, phytoestrogenic, and antioxidative role of Labisia pumila in prevention of postmenopausal osteoporosis. Adv. Pharmacol. Sci. 2012, 706905 (2012)
A.H. Myers, E.G. Robinson, M.L. Van Natta, J.D. Michelson, K. Collins, S.P. Baker, Hip fractures among the elderly: factors associated with in-hospital mortality. Am. J. Epidemiol. 134(10), 1128–1137 (1991)
H. Zhang, X. Chai, S. Li et al., Age-related changes in body composition and their relationship with bone mineral density decreasing rates in central south Chinese postmenopausal women. Endocrine (2012). [Epub ahead of print]
S.H. Ralston, B. de Crombrugghe, Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 20(18), 2492–2506 (2006)
T. Harsløf, L.B. Husted, M. Carstens, L. Stenkjaer, B.L. Langdahl, Genotypes and haplotypes of the estrogen receptor genes, but not the retinoblastoma-interacting zinc finger protein 1 gene, are associated with osteoporosis. Calcif. Tissue Int. 87(1), 25–35 (2010)
J. Zupan, S. Mencej-Bedrac, S. Jurković-Mlakar, J. Prezelj, J. Marc, Gene–gene interactions in RANK/RANKL/OPG system influence bone mineral density in postmenopausal women. J. Steroid Biochem. Mol. Biol. 118(1–2), 102–106 (2010)
H. Jin, R.J. van’t Hof, O.M. Albagha, S.H. Ralston, Promoter and intron 1 polymorphisms of COL1A1 interact to regulate transcription and susceptibility to osteoporosis. Hum. Mol. Genet. 18(15), 2729–2738 (2009)
T.L. Yang, Y. Guo, Y.J. Liu et al., Genetic variants in the SOX6 gene are associated with bone mineral density in both Caucasian and Chinese populations. Osteoporos. Int. 23(2), 781–787 (2012)
N. Zamani, C.W. Brown, Emerging roles for the transforming growth factor-{beta} superfamily in regulating adiposity and energy expenditure. Endocr. Rev. 32(3), 387–403 (2011)
T. Simopoulou, K.N. Malizos, D. Iliopoulos et al., Differential expression of leptin and leptin’s receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 15(8), 872–883 (2007)
Y. Fujita, K. Watanabe, K. Maki, Serum leptin levels negatively correlate with trabecular bone mineral density in high-fat diet-induced obesity mice. J. Musculoskelet. Neuronal Interact. 12(2), 84–94 (2012)
T. Iida, T. Domoto, A. Takigawa et al., Relationships among blood leptin and adiponectin levels, fat mass, and bone mineral density in Japanese pre- and postmenopausal women. Hiroshima J. Med. Sci. 60(4), 71–78 (2011)
E.L. Scheller, J. Song, M.I. Dishowitz, K.D. Hankenson, P.H. Krebsbach, A potential role for the myeloid lineage in leptin-regulated bone metabolism. Horm. Metab. Res. 44(1), 1–5 (2012)
G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatments for osteoporosis. Endocrine 41(1), 58–69 (2012)
R. Aller, D.A. De Luis, O. Izaola et al., Lys656Asn polymorphism of leptin receptor, leptin levels and insulin resistance in patients with non alcoholic fatty liver disease. Eur. Rev. Med. Pharmacol. Sci. 16(3), 335–341 (2012)
T. Montalcini, S. Romeo, Y. Ferro, V. Migliaccio, C. Gazzaruso, A. Pujia, Osteoporosis in chronic inflammatory disease: the role of malnutrition. Endocrine 43(1), 59–64 (2013)
F. Procianoy, E. Procianoy, Orbital inflammatory disease secondary to a single-dose administration of zoledronic acid for treatment of postmenopausal osteoporosis. Osteoporos. Int. 21(6), 1057–1058 (2010)
G. Musso, Non-alcoholic fatty liver, adipose tissue, and the bone: a new triumvirate on the block. Endocrine 42(2), 237–239 (2012)
S.C. Manolagas, R.L. Jilka, Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N. Engl. J. Med. 332(5), 305–311 (1995)
S. Low, M.C. Chin, S. Ma, D. Heng, M. Deurenberg-Yap, Rationale for redefining obesity in Asians. Ann. Acad. Med. Singapore 38(1), 66–69 (2009)
C. Gabay, M.G. Dreyer, N. Pellegrinelli, R. Chicheportiche, C.A. Meier, Leptin directly induces the secretion of interleukin 1 receptor antagonist in human monocytes. J. Clin. Endocrinol. Metab. 86(2), 783–791 (2001)
Y. Guo, H. Liu, T.L. Yang et al., The fat mass and obesity associated gene, FTO, is also associated with osteoporosis phenotypes. PLoS ONE 6(11), e27312 (2011)
J. Cieslak, M. Bartz, M. Stachowiak et al., Effect of three common SNPs in 5′-flanking region of LEP and ADIPOQ genes on their expression in Polish obese children and adolescents. Mol. Biol. Rep. 39(4), 3951–3955 (2012)
A. Gippini, A. Mato, R. Peino, M. Lage, C. Dieguez, F.F. Casanueva, Effect of resistance exercise (body building) training on serum leptin levels in young men. Implications for relationship between body mass index and serum leptin. J. Endocrinol. Invest. 22(11), 824–828 (1999)
K. Snoussi, A.D. Strosberg, N. Bouaouina, S. Ben Ahmed, A.N. Helal, L. Chouchane, Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 6, 38 (2006)
R.R. McLean, Proinflammatory cytokines and osteoporosis. Curr. Osteoporos. Rep. 7(4), 134–139 (2009)
B. Canavan, R.O. Salem, S. Schurgin et al., Effects of physiological leptin administration on markers of inflammation, platelet activation, and platelet aggregation during caloric deprivation. J. Clin. Endocrinol. Metab. 90(10), 5779–5785 (2005)
C. Martin-Romero, J. Santos-Alvarez, R. Governa, V. Sanchez-Margalet, Human leptin enhances activation and proliferation of human circulating T lymphocytes. Cell. Immunol. 199(1), 15–24 (2000)
S. Agrawal, S. Gollapudi, H. Su, S. Gupta, Leptin activates human B cells to secrete TNF-α, IL-6, and IL-10 via JAK2/STAT3 and p38MAPK/ERK1/2 signaling pathway. J. Clin. Immunol. 31(3), 472–478 (2011)
Acknowledgments
The authors would like to thank Xiaomei Lin for statistical analysis and technical support.
Conflict of interest
The authors have no potential conflict of interest of relevance to this article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ye, X.L., Lu, C.F. Association of polymorphisms in the leptin and leptin receptor genes with inflammatory mediators in patients with osteoporosis. Endocrine 44, 481–488 (2013). https://doi.org/10.1007/s12020-013-9899-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-9899-9